Intrinsic Value of S&P & Nasdaq Contact Us

Aardvark Therapeutics, Inc. Common Stock AARD NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
51/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$29.33
+477.4%

Stock Statistics — AARD

Aardvark Therapeutics, Inc. Common Stock (AARD) has a market capitalization of $110.83M and trades at $5.08. The 52-week range is 3.35-17.94.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.7, Earnings Per Share (EPS) of $-2.93.

The stock has a beta of 3.13, operates in the Healthcare sector.

Trading Data
Current Price$5.08
52-Week Range3.35-17.94
Volume285.24K
Avg Volume (30D)291.02K
Market Cap$110.83M
Beta (1Y)3.13
Company
IPO Date2025-02-13
Employees22
CEOTien-Li Lee
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS0029421007
CUSIP002942100
Income (Latest Year)
Gross Profit$-36K
EBITDA$-62.73M
Operating Income$-62.73M
Net Income$-57.59M
EPS$-2.93
EPS Diluted$-2.93
Shares Outstanding$19.62M
Balance Sheet (Latest Year)
Total Assets$117.18M
Current Assets$111.89M
Cash & ST Investments$110.03M
Total Liabilities$10.55M
Total Debt$441K
Net Debt$-46.61M
Total Equity$106.63M
Debt / Equity0.00
Valuation Ratios
P/E Ratio-1.7
P/B Ratio1.04
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message